MedPath

Comparative Effects of Conventional Physical Therapy, Kinesio Taping and ESWT in Upper Trapezius MPS.

Not Applicable
Completed
Conditions
Trapezius Muscle Strain
Registration Number
NCT05277259
Lead Sponsor
Yuzuncu Yıl University
Brief Summary

There is no study in the literature comparing both kinesiotaping and Extracorporeal Shock Wave Therapy (ESWT) with conventional physical therapy in upper trapezius myofascial pain syndrome. In this study, we aimed to make this comparison.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
99
Inclusion Criteria
  • Presence of at least 1 active trigger point in the upper trapezius muscle, exacerbation of pain when this point(s) is pressed, painful limitation of cervical lateral flexion and extension.
Exclusion Criteria
  • Having a history of spine and upper extremity surgery, neuromuscular disease, active rheumatologic disease, active infection, malignancy, having previously applied ESWT or Kinesio Taping to the back and neck region.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Neck Disability Index (NDI)6 weeks after baseline (one month after the end of treatment)

a self-report questionnaire used to determine how neck pain affects a patient's daily life and to assess the self-rated disability of patients with neck pain. The total score ranges from 0 (no disability) to 50 (total disability).

Visual Analogue Scale (VAS)6 weeks after baseline (one month after the end of treatment)

patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse outcome

Secondary Outcome Measures
NameTimeMethod
Measurement of Cervical range of motion (Cervikal ROM)6 weeks after baseline (one month after the end of treatment)

Measuring cervical lateral flexion and cervical extension with a manual goniometer.

Trial Locations

Locations (1)

Yuzuncu Yil University

🇹🇷

Van, Turkey

Yuzuncu Yil University
🇹🇷Van, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.